Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cutolo

Showing results (251-260 of 274) with videos related to

Pageof 28
Sort By:
Journal of Endocrinological Investigation|May 26, 2020
Body composition and bone status in relation to microvascular damage in systemic sclerosis patientsS Paolino, E Gotelli, F Goegan, et al.
Annals of the Rheumatic Diseases|January 14, 2005
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparisonM Cutolo, G J M Maestroni, K Otsa, et al.
Rheumatology (Oxford, England)|January 4, 2021
Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA studyT Santiago, M Voshaar, M de Wit, et al.
Clinical and Experimental Rheumatology|February 10, 2006
Localized and systemic forms of scleroderma in adults and children F Atzeni, A Bardoni, M Cutolo, et al.
Reumatismo|January 9, 2014
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritisM Todoerti, W Maglione, E Bernero, et al.
Annals of the Rheumatic Diseases|July 16, 2002
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyF Buttgereit, J A P da Silva, M Boers, et al.
The Journal of Rheumatology|October 24, 2001
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritisC Salvarani, P Macchioni, I Olivieri, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.
Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Pageof 28

Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Journal of Endocrinological Investigation|May 26, 2020
Body composition and bone status in relation to microvascular damage in systemic sclerosis patientsS Paolino, E Gotelli, F Goegan, et al.
Annals of the Rheumatic Diseases|January 14, 2005
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparisonM Cutolo, G J M Maestroni, K Otsa, et al.
Rheumatology (Oxford, England)|January 4, 2021
Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA studyT Santiago, M Voshaar, M de Wit, et al.
Clinical and Experimental Rheumatology|February 10, 2006
Localized and systemic forms of scleroderma in adults and children F Atzeni, A Bardoni, M Cutolo, et al.
Reumatismo|January 9, 2014
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritisM Todoerti, W Maglione, E Bernero, et al.
Annals of the Rheumatic Diseases|July 16, 2002
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyF Buttgereit, J A P da Silva, M Boers, et al.
The Journal of Rheumatology|October 24, 2001
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritisC Salvarani, P Macchioni, I Olivieri, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.
Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Pageof 28